经肝动脉灌注^131 I-HAblSF（ab’）2治疗肝癌合并门静脉癌栓疗效分析

目的探讨经肝动脉灌注^131 I-HAbl8F（ab’）2治疗肝癌合并门脉癌栓的价值。方法8例合并门脉癌栓的晚期肝癌患者行经肝动脉超选择灌注^131 I-HAbl8F（ab＇）2临床治疗性试验，剂量：0．75mCi／kg。分析症状、卡氏评分、肝功能、AFP及肿瘤CT等影像变化，随访近期疗效。结果7例疼痛患者中，3例症状缓解。3例卡氏评分增加、4例稳定。6例AFP异常患者治疗后3例下降。全组病例用药后肝功能损害均无明显加重。1例无明显症状的弥漫型肝癌患者治疗后病灶减少；余7例中，瘤体增大5例、缩小2例，其中，PR2例，临床有效率28．6％。本组1例1年随访时生存。结论经肝动脉灌注0．75mCi／kg ^131 I-HAbl8F（ab＇）2对合并门脉癌栓的肝癌患者肝功影响小，对门脉分支癌栓患者有较好的疗效。     

ENDOSCOPIC PANCREATIC STENTING IN CHRONIC PANCREATITIS WITH DUCTAL DILATION PROXIMAL TO A STRICTURE: A SAFE and EFFECTIVE PROTOCOL

After removal of intraductal stones, a 10‐Fr or 7‐Fr pancreatic stent was placed in 16 patients with upstream ductal dilation proximal to a stricture of the main pancreatic duct. Stents were removed after a mean duration of 52.5 days. Nine patients underwent repeated stenting. About one year after removal of the initial stent, when the remaining upstream ductal dilation was found on follow‐up pancreatograms, the next stent was replaced. Repeated stenting improved outflow of pancreatic juice more effectively than one‐time stenting. Correlation between long‐term pain relief without recurrence of intraductal stones and reduction of duct diameter was also shown. Stent occlusion was observed in 14 of 30 stents. Stent occlusion was frequently associated with recurrence of pancreatitis and intraductal stones, and was also associated with morphologic changes in the pancreatic ductal system. Although there were no significant differences between stent patency of the initial stents and that of the next stents, stent patency of 10‐Fr stents was superior to that of 7‐Fr stents. 10‐Fr stents should be removed within 8 weeks and 7‐Fr stents should be removed within 4 weeks for the prevention of stent occlusion. Repeated stenting with short‐term stenting is therefore considered a safe and effective protocol of endoscopic pancreatic stenting.     

蜂毒素微球经动脉介入治疗大鼠肝癌的实验研究

目的:观察蜂毒素微球(M-MS)经动脉介入对大鼠肝癌的治疗作用.方法:采用改良的复乳-液中干燥法制备蜂毒素-聚乳酸/羟乙酸微球,建立大鼠移植性肝癌模型并随机分为四组,分别经肝动脉灌注生理盐水(NS,1.5ml/kg)、蜂毒素(Melittin,0.35mg/kg)、空白微球(B-MS,10mg/kg)和蜂毒素-聚乳酸/羟乙酸微球(10mg/kg).比较治疗后各组大鼠的肿瘤生长情况、肿瘤坏死程度和生存时间.结果:与生理盐水组比较,Melittin组、B-MS组肿瘤生长受到明显抑制(P<0.01),肿瘤坏死程度以轻中度为主,但两组动物生存时间均未能明显延长(P>0.05).M-MS组与NS组、Melittin组及B-MS组相比,肿瘤生长抑制显著(P<0.01),肿瘤坏死更广泛、更彻底,且经蜂毒素微球治疗的大鼠生存期显著延长(P<0.01).结论:蜂毒素以药物微球的剂型经肝动脉给药,抗肿瘤效果明显优于单纯的蜂毒素和空白微球.     

体外反搏治疗血清对培养内皮细胞基因表达的影响

目的探讨经体外反搏治疗的冠心病患者血清对血管内皮细胞基因表达的调控效应。方法分别取接受体外反搏治疗的冠心病患者1、24和36h时间点的血清，用于培养人脐静脉血管内皮细胞。用cDNA基因芯片检测3个治疗时点反搏前、后血管内皮细胞基因表达谱。结果反搏前后比较，有10个基因（核转录因子、真核转录启动因子-4、平滑肌的肌球蛋白重链、α2-肌动蛋白、微管蛋白β肽链、组织相容蛋白G、黑色素黏附分子、神经介素B受体、蛋白激酶4K2、血小板凝血酶敏感蛋白-1）的表达在3个治疗时点上出现显著改变。在1h点均为上调，在24h、36h时点均为下调。结论体外反搏治疗冠心病患者血清对血管内皮细胞的炎症反应、细胞凋亡相关基因表达有调效应，并随体外反搏治疗时间的增加早抑制其表达的趋势。     

彩色多普勒超声诊断飞行员左冠状动脉-肺动脉瘘一例并文献复习

目的 探讨冠状动脉瘘的影像特征、鉴别诊断及彩色多普勒超声在飞行员改装体检中的医学鉴定价值.方法 分析1例飞行员左冠状动脉-肺动脉瘘超声图像特征并复习相关文献.探讨应用彩色多普勒超声检查在飞行员改装体检中的必要性.结果 彩色多普勒超声显示心底部心肌间走行迂曲的异常血流束,经主肺动脉外侧壁注入肺动脉内.超声诊断:左冠状动脉-肺动脉瘘.飞行结论:改装并原机种飞行不合格结论彩色多普勒超声检查能清晰显示冠状动脉瘘,并能追踪观察其走行、部位、内径和大小,超声诊断与冠状动脉造影结果相符.冠状动脉瘘早期无特异性临床表现,彩色多普勒超声心动图诊断冠状动脉瘘直接、安全、快捷,具有重要的临床价值,是明确诊断的首选方法.     

Prevalence of silent myocardial ischemia in asymptomatic individuals with subclinical atherosclerosis detected by electron beam tomography

BACKGROUND: Electron beam tomography coronary calcium imaging is an evolving technique for the early detection of coronary atherosclerosis, and recent studies have established its prognostic value in asymptomatic individuals. The relationship of coronary artery calcium scores (CAC) to obstructive coronary artery disease (CAD) has been poorly studied but is clinically relevant because it determines which individuals are likely to benefit from revascularization procedures. Hence, we prospectively evaluated the prevalence of myocardial ischemia in asymptomatic patients with cardiovascular risk factors and subclinical atherosclerosis. METHODS AND RESULTS: We studied 864 asymptomatic patients with no previous CAD but with cardiovascular risk factors, referred for electron beam tomography coronary calcium imaging to our institution over an 18-month period. From this group, 220 consecutive patients (85% men; mean age, 61 +/- 9 years; age range, 31-84 years) with moderate to severe atherosclerotic disease (coronary calcium score > or =100 Agatston units) were prospectively evaluated by technetium 99m sestamibi single photon emission computed tomography (SPECT). Patients were followed up (mean follow-up, 14 months) and data regarding their subsequent clinical management recorded. Of the 220 patients, 119 had moderate atherosclerosis (CAC score of 100-400 Agatston units) and 101 had severe atherosclerosis (CAC score > or =400 Agatston units). Abnormal SPECT findings were seen in 18% of patients with moderate atherosclerosis (n = 21) and 45% of patients with severe atherosclerosis (n = 45). Increasing severity of atherosclerosis was related to increasing ischemic burden (summed difference score = 1 +/- 0.2 for CAC score of 100-400 Agatston units and 3.2 +/- 0.5 for CAC score > or =400 Agatston units). In a multivariate linear regression model incorporating risk factors, CAC was the only predictor of silent ischemia. CONCLUSION: In comparison to previously published data, we detected a higher prevalence of silent ischemia even in patients with moderate coronary atherosclerosis (18%). This may reflect the differing risk factor profile of our patient population. When coronary calcium screening is used to preselect asymptomatic patients with cardiovascular risk factors for myocardial perfusion imaging, the optimum coronary calcium score threshold will depend on the population prevalence of risk factors and asymptomatic obstructive CAD.     

不同血管保存液对人桡动脉血管移植物的抗痉挛作用

目的 研究不同的血管保存液对人离体桡动脉痉挛的缓解与预防能力。方法 非体外循环冠状动脉旁路手术(OPCAB)19例患者,应用“无接触(No Touch)”外科技术获取自体桡动脉,保留未处理的远段0.8～1.5cm。应用血管环灌流技术(Organ Bath)比较不同保存液的抗痉挛作用和预防痉挛作用。结果 血管环灌流实验显示,在对痉挛状态桡动脉的舒张能力方面,PS、VG、DG、NG溶液均可以在10min内100％舒张血管,舒张曲线显示舒张能力依次为VG、DG、NG、PS,但差异无显著性(P>0.05),在预先浸泡处理桡动脉45～60min后,除对照组(Ringer's Solution)外,所有血管保存液均可以有效地预防离体桡动脉的痉挛,各组间差异无显著性(P>0.05)。结论 罂粟碱溶液、VG、DG、NG溶液均有较好的抗血管痉挛作用,单从抗血管痉挛角度考虑可以用作CABG手术中桡动脉的准备液。     

面神经颅外段血供的应用解剖学研究

目的探讨面神经颅外段的动脉来源及分布. 方法 15例新鲜尸体头颈部标本经双侧颈总动脉插管,加压注入红色乳胶或过氯乙烯填充剂,观察面神经颅外段的血供来源及分布. 结果面神经营养动脉来源于耳后动脉的茎乳动脉、颞浅动脉面神经支、面横动脉、颈外动脉上面神经支、颈外动脉下面神经支、面动脉后面神经支和面动脉前面神经支,其外径分别为(0.8±0.2) mm、(0.9±0.4) mm、(1.9±0.3) mm、(1.0±0.2) mm、(1.1±0.4) mm、(1.0±0.2) mm和(1.1±0.6) mm.各营养动脉除营养面神经外还发出分支相互吻合,构成了丰富的面神经血管网. 结论了解面神经颅外段动脉血供来源及分布,为避免腮腺咬肌区手术损伤面神经营养血管提供了解剖学基础.     

改良后的家兔动脉深低温保存实验研究

目的：为探讨家兔动脉在改良的深低温保存后，其作为血管材料替代物的优越性。方法：无菌条件下取新鲜兔动脉，分别给予改良后的营养液经慢速深低温冷冻和快速深低温冷冻处理，6个月后异体和自体移植，12周后，取移植的血管组织，观测其组织活性，组织形态、血管通畅率。结果：改良的营养液保护的血管经慢冻法处理后与自体血管活性相近，经改良的营养液保护的血管，移植前后血管内膜的连续性，血管的组织结构良好；慢冻法处理的血管通畅率比速冻法处理的高，与自体移植组相当。结论：复方氨基酸可以替代传统冷冻保护液中的小牛血清用于血管的深低温保存，降低了该保存技术的成本；快速深低温冷冻保存的动脉血管活力移植效果不如慢速冷冻处理的异体动脉好。     

阿托伐他汀对冠心病患者肱动脉内皮依赖性舒张功能的影响

目的：应用高频超声观察冠心病（CAD）患者，经阿托伐他汀治疗后对肱动脉内皮依赖性舒张功能（EDD）的改善作用。方法：经冠脉造影（CAG）确诊为CAD患者59例，利用高频超声血管技术检测阿托伐他汀对CAD患者治疗前后肱动脉EDD的疗效。结果：阿托伐他汀治疗2年后，EDD比治疗前有明显改善（P〈0．05），与对照组相比无显著性差异（P〉0．05）。常规治疗组治疗2年后，EDD无明显改善（P〉0．05），与阿托伐他汀组治疗后及对照组相比差异有显著性（P〈0．05）。结论：阿托伐他汀具有改善EDD的作用。